Brian has long said that health care needs a start, not a finish. With the passage of the 2009 Patient Protection and Affordable Care Act, our nation took a critical first step by giving millions of Americans access to health insurance, including those who had never had access before, like individuals with pre-existing conditions, and making sure that the high cost of medical treatments do not force families into bankruptcy. Brian supports efforts in Congress to come together across the aisle and improve the law, bringing down the cost curve and making the quality of care better for all Americans.
More on Health Care
Congressman Brian Higgins (NY-26) announced today that Buffalo biopharmaceutical company Cleveland BioLabs, Inc. has been awarded a grant of up to $6.6 million from the Department of Defense. This award will fund a clinical study designed to support a Biologics License Application (BLA) for entolimodas a medical radiation countermeasure.
Congressman Brian Higgins (NY-26) is calling on Congress to move swiftly to approve James Zadroga 9/11 Health and Compensation Reauthorization Act.
“As the world remembers the day forever etched in the hearts and minds of Americans, the best way to honor those lost is to look out for their families and the thousands who were present at the time of the attacks and in the days that followed,” said Higgins.
BUFFALO, N.Y. — The University at Buffalo has been awarded a prestigious, four-year, $16 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH) to speed the delivery of new drugs, diagnostics and medical devices to patients.
The grant will establish the UB Clinical and Translational Research Center as the hub of the Buffalo Translational Consortium. UB is the lead institution of the consortium in partnership with Roswell Park Cancer Institute, the Great Lakes Health System, UBMD and community health organizations.
Congressman Brian Higgins (NY-26) commends Carl Morrison, MD, DVM, of Roswell Park Cancer Institute (RPCI) on his appointment to the federal Advisory Panel on Clinical Diagnostic Laboratory Tests. The new 15-member panel has been established by the Centers for Medicare & Medicaid Services (CMS), a division of the U.S. Department of Health and Human Services, to help guide and inform CMS leadership on decisions and policies regarding new diagnostic laboratory tests.
Congressman Brian Higgins (NY-26) announces the formation of the National Institutes of Health (NIH) Caucus, dedicated to increasing NIH funding and support for biomedical research. Higgins co-chairs the NIH Caucus with Representatives Rosa DeLauro (CT-3) and Peter King (NY-2).
Congressman Brian Higgins (NY-26) recognized February 4, 2015 as World Cancer Day by announcing the introduction of legislation aimed at the fight to rid the world of cancer and other debilitating diseases.
Congressman Brian Higgins (NY-26) recently spoke on the House floor in support of increased funding for medical research. Adjusting for inflation, the National Institutes of Health (NIH) receive nearly 25 percent less funding today than it did in 2003. This is why Congressman Higgins recently joined Congresswoman DeLauro to introduce H.R. 5580, the Accelerating Biomedical Research Act. This legislation will incrementally increase funding for the National Institutes of Health (NIH) over the next seven years.
BUFFALO, N.Y. (October 8, 2014) – Health care for kids and their mothers took a major leap forward today as Kaleida Health held a ceremonial groundbreaking for the new John R. Oishei Children’s Hospital.
Physicians, employees, donors, elected officials, and other dignitaries were on hand to kick off construction on the new $270 million facility.
Congressman Brian Higgins joined Congresswoman Rosa DeLauro in introducing H.R. 5580, the Accelerating Biomedical Research Act. This legislation will incrementally increase funding for the National Institutes of Health (NIH) over the next seven years. The DeLauro-Higgins bill is the House companion of S. 2658 introduced by Senator Harkin, a longstanding champion of NIH funding.